Risk of non-fatal cardiac failure and ischaemic heart disease with long acting beta 2 agonists.

  title={Risk of non-fatal cardiac failure and ischaemic heart disease with long acting beta 2 agonists.},
  author={R M Martin and N R Dunn and Shayne Freemantle and R D Mann},
  volume={53 7},
  • R M Martin, N R Dunn, +1 author R D Mann
  • Published 1998 in Thorax
BACKGROUND The long term safety of beta agonists, particularly in patients with heart disease, has not been fully established. METHODS This study accessed the results of three cohort studies involving: 12,294 patients receiving at least one prescription for nedocromil between November 1986 and September 1988; 15,407 patients prescribed salmeterol between December 1990 and May 1991; and 8098 patients prescribed bambuterol between February 1993 and December 1995. Details of all dispensed… CONTINUE READING

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
18 Extracted Citations
23 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 18 extracted citations

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 23 references

Drug treatment in heart failure : lowering heart rate may reduce mortality

  • RD Start, JP Bury, AG Strachan
  • BMJ
  • 1998

Additive beneficial e V ects of beta - blockers to angiotensin - converting enzyme inhibitors in the survival and ventricular enlargement study

  • RP Steeds, KS Channer
  • J Am Coll Cardiol
  • 1997

The incidence of the most commonly reported events with 40 newly marketed drugsa study by PrescriptionEvent Monitoring

  • SN Freemantle, GL Pearce, LV Wilton
  • Pharmacoepidemiology and Drug Safety
  • 1997

â – adrenergic bronchodilators

  • HS Nelson
  • N Engl J Med
  • 1995

Similar Papers

Loading similar papers…